Antibodies that bind to cancer-associated antigen cd46 and...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/28 (2006.01) A61K 38/16 (2006.01) A61K 39/395 (2006.01) A61K 39/44 (2006.01) A61K 47/48 (2006.01) A61P 35/00 (2006.01) C07K 16/30 (2006.01) C07K 16/46 (2006.01) C12N 5/10 (2006.01) C12P 21/08 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2463927

Provided herein is disclosure about the development and characterization of . an antibody (mP A 7) which binds to antigen CD46 which is present on a variety of human cancers from ovary, breast, lung, prostate, colon, kidney, and pancreas. Methods of diagnosing and treating various cancers by using antibodies such as mP A 7 directed against this antigen are also disclosed.

L'invention concerne le développement et la caractérisation d'un anticorps (mPA7) se liant à un antigène CD46 présent dans une pluralité de cancers humains, tels que le cancer de l'ovaire, du sein, du poumon, de la prostate, du côlon, du rein et du pancréas. L'invention concerne également des méthodes de diagnostic et de traitement d'une pluralité de cancers au moyen d'anticorps tels que mPA7 dirigés contre cet antigène.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antibodies that bind to cancer-associated antigen cd46 and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies that bind to cancer-associated antigen cd46 and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies that bind to cancer-associated antigen cd46 and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1647554

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.